Cargando…
A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells
Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-tes...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818597/ https://www.ncbi.nlm.nih.gov/pubmed/29110037 http://dx.doi.org/10.1007/s00204-017-2102-y |
_version_ | 1783301056852131840 |
---|---|
author | Wilde, Eleanor C. Chapman, Katherine E. Stannard, Leanne M. Seager, Anna L. Brüsehafer, Katja Shah, Ume-Kulsoom Tonkin, James A. Brown, M. Rowan Verma, Jatin R. Doherty, Ann T. Johnson, George E. Doak, Shareen H. Jenkins, Gareth J. S. |
author_facet | Wilde, Eleanor C. Chapman, Katherine E. Stannard, Leanne M. Seager, Anna L. Brüsehafer, Katja Shah, Ume-Kulsoom Tonkin, James A. Brown, M. Rowan Verma, Jatin R. Doherty, Ann T. Johnson, George E. Doak, Shareen H. Jenkins, Gareth J. S. |
author_sort | Wilde, Eleanor C. |
collection | PubMed |
description | Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-testing paradigm in human cancer risk assessment fail to accurately represent and predict whether a chemical causes human carcinogenesis. The study aimed to establish whether the integrated analysis of multiple cellular endpoints related to the Hallmarks of Cancer could advance in vitro carcinogenicity assessment. Human lymphoblastoid cells (TK6, MCL-5) were treated for either 4 or 23 h with 8 known in vivo carcinogens, with doses up to 50% Relative Population Doubling (maximum 66.6 mM). The adverse effects of carcinogens on wide-ranging aspects of cellular health were quantified using several approaches; these included chromosome damage, cell signalling, cell morphology, cell-cycle dynamics and bioenergetic perturbations. Cell morphology and gene expression alterations proved particularly sensitive for environmental carcinogen identification. Composite scores for the carcinogens’ adverse effects revealed that this approach could identify both DNA-reactive and non-DNA reactive carcinogens in vitro. The richer datasets generated proved that the holistic evaluation of integrated phenotypic alterations is valuable for effective in vitro risk assessment, while also supporting animal test replacement. Crucially, the study offers valuable insights into the mechanisms of human carcinogenesis resulting from exposure to chemicals that humans are likely to encounter in their environment. Such an understanding of cancer induction via environmental agents is essential for cancer prevention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-017-2102-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5818597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-58185972018-02-27 A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells Wilde, Eleanor C. Chapman, Katherine E. Stannard, Leanne M. Seager, Anna L. Brüsehafer, Katja Shah, Ume-Kulsoom Tonkin, James A. Brown, M. Rowan Verma, Jatin R. Doherty, Ann T. Johnson, George E. Doak, Shareen H. Jenkins, Gareth J. S. Arch Toxicol Genotoxicity and Carcinogenicity Human exposure to carcinogens occurs via a plethora of environmental sources, with 70–90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-testing paradigm in human cancer risk assessment fail to accurately represent and predict whether a chemical causes human carcinogenesis. The study aimed to establish whether the integrated analysis of multiple cellular endpoints related to the Hallmarks of Cancer could advance in vitro carcinogenicity assessment. Human lymphoblastoid cells (TK6, MCL-5) were treated for either 4 or 23 h with 8 known in vivo carcinogens, with doses up to 50% Relative Population Doubling (maximum 66.6 mM). The adverse effects of carcinogens on wide-ranging aspects of cellular health were quantified using several approaches; these included chromosome damage, cell signalling, cell morphology, cell-cycle dynamics and bioenergetic perturbations. Cell morphology and gene expression alterations proved particularly sensitive for environmental carcinogen identification. Composite scores for the carcinogens’ adverse effects revealed that this approach could identify both DNA-reactive and non-DNA reactive carcinogens in vitro. The richer datasets generated proved that the holistic evaluation of integrated phenotypic alterations is valuable for effective in vitro risk assessment, while also supporting animal test replacement. Crucially, the study offers valuable insights into the mechanisms of human carcinogenesis resulting from exposure to chemicals that humans are likely to encounter in their environment. Such an understanding of cancer induction via environmental agents is essential for cancer prevention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-017-2102-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-11-06 2018 /pmc/articles/PMC5818597/ /pubmed/29110037 http://dx.doi.org/10.1007/s00204-017-2102-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Genotoxicity and Carcinogenicity Wilde, Eleanor C. Chapman, Katherine E. Stannard, Leanne M. Seager, Anna L. Brüsehafer, Katja Shah, Ume-Kulsoom Tonkin, James A. Brown, M. Rowan Verma, Jatin R. Doherty, Ann T. Johnson, George E. Doak, Shareen H. Jenkins, Gareth J. S. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title_full | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title_fullStr | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title_full_unstemmed | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title_short | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
title_sort | novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells |
topic | Genotoxicity and Carcinogenicity |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818597/ https://www.ncbi.nlm.nih.gov/pubmed/29110037 http://dx.doi.org/10.1007/s00204-017-2102-y |
work_keys_str_mv | AT wildeeleanorc anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT chapmankatherinee anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT stannardleannem anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT seagerannal anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT brusehaferkatja anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT shahumekulsoom anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT tonkinjamesa anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT brownmrowan anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT vermajatinr anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT dohertyannt anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT johnsongeorgee anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT doakshareenh anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT jenkinsgarethjs anovelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT wildeeleanorc novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT chapmankatherinee novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT stannardleannem novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT seagerannal novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT brusehaferkatja novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT shahumekulsoom novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT tonkinjamesa novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT brownmrowan novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT vermajatinr novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT dohertyannt novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT johnsongeorgee novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT doakshareenh novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells AT jenkinsgarethjs novelintegratedinvitrocarcinogenicitytesttoidentifygenotoxicandnongenotoxiccarcinogensusinghumanlymphoblastoidcells |